
The Weekly Roundup: July 14-18
Key Takeaways
- Melanoma survivors advocate for early detection, routine skin exams, and public education to improve outcomes.
- Boehringer Ingelheim and LEO Pharma collaborate to advance Spesolimab for generalized pustular psoriasis (GPP).
In case you missed it, this week we had news about the launch of deuruxolitinib for alopecia areata, Treg cel impairment in vitiligo, the top aesthetic innovations of this month, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our
Melanoma survivors share their diagnoses and advocate for early detection, routine skin exams, and public education to save lives.
The pharmaceutical companies announced an exclusive global license and transfer agreement for the advancement and commercialization of Spevigo.
Sun Pharmaceuticals has launched deuruxolitinib (Leqselvi) in the US, offering a new treatment for adults with severe alopecia areata.
A national Delphi survey reveals critical insights into CHE management in France, highlighting the need for standardized assessment and guidelines.
Both regulatory-approved and pipeline treatments for moderate to severe HS demonstrate comparable efficacy and safety, offering hope for patients often dissatisfied with current treatment options.
Turn Therapeutics initiates a groundbreaking clinical trial for GX-03, the first topical IL-36 inhibitor targeting moderate to severe eczema.
Renata Block, DMSc, MMS, PA-C, interviews Amy Snow, PA-C, who shares how she transformed career roadblocks into a mobile dermatology clinic delivering free care and hope across Oregon.
Haut.AI has launched the SPF Truth Booth and SPF Protection Power List, using AI to promote sun safety and personalized patient insights.
New insights reveal shared and allergen-specific immune responses in allergic contact dermatitis.
Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of July.
For pregnant women, formulations with niacinamide, vitamin E, hyaluronic acid, and peptides may help support barrier function and reduce pigmentation without compromising safety.
A recent study reveals distinct patterns of nonsegmental vitiligo lesions on hands.
This review of the latest dermatologic studies includes insights into ocular safety during laser procedures, radiation dermatitis prevention and management, and more.
Discover how trifarotene, a novel retinoid, effectively addresses adult acne and its long-term effects, enhancing skin health and quality of life.
Aesthetic medicine embraces a holistic approach to skin quality, defining it through measurable categories that enhance personalized treatment strategies.
Explore how genetic factors influence acute and chronic urticaria, revealing potential for personalized treatment strategies.
A systematic review reveals significant Treg cell deficiencies in vitiligo, highlighting their role as therapeutic targets for improved treatment strategies.
A first-of-its-kind study reveals AI-driven insights on hair loss trends, highlighting the impact of genetics, hormones, and COVID-19 on alopecia.
With longer visits and flat-rate pricing, Kment’s practice provides personalized dermatologic care to both insured and uninsured patients.
Art transforms dermatology by fostering dialogue, enhancing patient connection, and challenging biases, as medical students explore creative expression in health care.
Our July cover story explores effective treatments for hidradenitis suppurativa, including procedural interventions and advanced therapies that enhance patient quality of life.
Abrocitinib significantly improves lesion severity and pruritus in moderate to severe AD, offering a promising treatment option for patients.
Rigorous pre-, intra-, and postoperative protocols help ensure safe, effective periocular laser treatments and reduce the risk of ocular complications.
New survey data reveals gaps in atopic dermatitis treatment for pregnant women, highlighting the need for updated guidelines and better physician education.
Jacki Kment, PA-C, MPAS, DFAAPA, shares how she built a successful direct pay dermatology practice to prioritize patient care and professional balance.
Hershel Dobkin, MD, FAAD, shares his experiences and the surprising reasons behind clinic delays, from patient needs to unexpected moments.
Experts share how this year's RAD Conference showcased cutting-edge advancements in atopic dermatitis to enhance patient care and treatment strategies.
Global acne burden in reproductive-age women has risen significantly, with greater increases expected by 2040.
Elderly patients show lower and more mild patch test reactivity than younger individuals, with different sensitization patterns.
Social media spreads significant retinol misinformation, risking adolescent skin health. Experts call for improved digital education and accurate content creation.
New research highlights the significant impact of dermatological diseases on work-life balance, revealing greater burdens for women compared to men.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















